tuftsin has been researched along with Benign Neoplasms in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (69.23) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Khan, MA | 1 |
| Cholewinski, G; Dzierzbicka, K; Gensicka-Kowalewska, M; Siebert, A | 1 |
| Tweedle, MF | 1 |
| Hadden, JW | 1 |
| Miarka, J; Polko, M; Straszecka, J | 1 |
| Catane, R; Fridkin, M; Fuks, Z; Gottlieb, P; Penchas, S; Schlanger, S; Treves, AJ; Weiss, L | 1 |
| Bruley-Rosset, M; Florentin, I; Mathè, G | 1 |
| Chaudhuri, MK; Konopinska, D; Linehan, L; Najjar, VA; Schmidt, DE | 1 |
| Fridkin, M; Gottlieb, P | 1 |
| Dzierzbicka, K; Kołodziejczyk, AM; Rakowski, T | 1 |
| MacEwen, EG | 1 |
| Fridkin, M; Najjar, VA | 1 |
| Mathé, G | 1 |
8 review(s) available for tuftsin and Benign Neoplasms
| Article | Year |
|---|---|
Targeted Drug Delivery Using Tuftsin-bearing Liposomes: Implications in the Treatment of Infectious Diseases and Tumors.
Topics: Animals; Communicable Diseases; Drug Delivery Systems; Liposomes; Mice; Neoplasms; Tuftsin | 2021 |
Tuftsin - Properties and Analogs.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Colitis; Cytokines; Fullerenes; Humans; Mycobacterium tuberculosis; Neoplasms; T-Lymphocytes; Tuftsin | 2017 |
[Tuftsin--physiological and clinical aspects and perspectives of its therapeutic use].
Topics: Adjuvants, Immunologic; Adult; Anesthetics; Animals; Antineoplastic Agents; Child; Humans; In Vitro Techniques; Mice; Neoplasms; Phagocyte Bactericidal Dysfunction; Phagocytosis; Rats; Tuftsin | 1983 |
Tuftsin, Thr-Lys-Pro-Arg. Anatomy of an immunologically active peptide.
Topics: Amino Acid Sequence; Animals; Bacteria; Cell Movement; Immunization; Immunoglobulin Fc Fragments; Immunoglobulin Fragments; Macrophages; Monocytes; Neoplasms; Neutrophils; Nitroblue Tetrazolium; Oxygen Consumption; Phagocytosis; Radioimmunoassay; Structure-Activity Relationship; Time Factors; Tuftsin | 1981 |
[Tuftsin--endogenous immunomodulator].
Topics: Adjuvants, Immunologic; Animals; Bacterial Infections; Humans; Neoplasms; Tuftsin; Virus Diseases | 2000 |
Approaches to cancer therapy using biological response modifiers.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Antibodies, Monoclonal; Bacterial Vaccines; BCG Vaccine; Blood Proteins; Cat Diseases; Cats; Cell Wall; Dog Diseases; Dogs; Immunotherapy; Interferon Inducers; Interferons; Liposomes; Lymphokines; Neoplasms; Staphylococcal Protein A; Tuftsin | 1985 |
Tuftsin: its chemistry, biology, and clinical potential.
Topics: Adult; Animals; Chemical Phenomena; Chemistry; Dogs; Granulocytes; Humans; Macrophages; Mice; Neoplasms; Tuftsin | 1989 |
Do tuftsin and bestatin constitute a biopharmacological immunoregulatory system?
Topics: Adjuvants, Immunologic; Animals; Humans; Immunotherapy; Leucine; Neoplasms; Phagocytosis; Tuftsin | 1987 |
1 trial(s) available for tuftsin and Benign Neoplasms
| Article | Year |
|---|---|
Toxicology and antitumor activity of tuftsin.
Topics: Adult; Aged; Aging; Animals; Clinical Trials as Topic; Cytotoxicity, Immunologic; Dogs; Female; Fibrosarcoma; Humans; Lethal Dose 50; Leukocyte Count; Leukocytosis; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Middle Aged; Neoplasm Transplantation; Neoplasms; Spleen; T-Lymphocytes, Cytotoxic; Tuftsin | 1983 |
4 other study(ies) available for tuftsin and Benign Neoplasms
| Article | Year |
|---|---|
Peptide-targeted diagnostics and radiotherapeutics.
Topics: Amino Acid Sequence; Angiogenesis Inhibitors; Animals; Cell Line; ErbB Receptors; Gadolinium; Humans; Lutetium; Male; Molecular Sequence Data; Neoplasms; Oligopeptides; Peptides; Positron-Emission Tomography; Prostatic Neoplasms; Protein Binding; Radiopharmaceuticals; Rats; Receptors, G-Protein-Coupled; Tuftsin | 2009 |
Chemically defined immunotherapeutic agents.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Aziridines; Benzimidazoles; Cimetidine; Ditiocarb; Humans; Hypoxanthines; Inosine Pranobex; Leucine; Levamisole; Mice; Neoplasms; Pyran Copolymer; Tuftsin | 1983 |
Macrophage activation by tuftsin and muramyl-dipeptide.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Animals; Cell Division; Glycopeptides; Immunoglobulin Fragments; Macrophage Activation; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasms; Tuftsin | 1981 |
Tuftsin, a natural activator of phagocytic functions including tumoricidal activity.
Topics: Animals; Antibody-Dependent Cell Cytotoxicity; Cell Differentiation; Female; Immunoglobulin Fragments; Leukemia L1210; Macrophages; Mice; Mice, Inbred DBA; Neoplasms; Oligopeptides; Phagocytosis; Tuftsin | 1981 |